Have a personal or library account? Click to login
Treatment-Refractory Eosinophilic Esophagitis Successfully Managed with benralizumab: A Case Presentation and literature review Cover

Treatment-Refractory Eosinophilic Esophagitis Successfully Managed with benralizumab: A Case Presentation and literature review

Open Access
|Jun 2024

References

  1. SYVERSON E. P., HAIT E. Update on Emerging Pharmacologic Therapies for Patients With Eosinophilic Esophagitis, Gastroenterol. Hepatol., vol. 18, no. 4, pp. 207212, Apr. 2022.
  2. COLLINS M. H., CAPOCELLI K., YANG G.-Y. Eosinophilic Gastrointestinal Disorders Pathology, Front. Med., vol. 4, p. 261, 2017.
  3. ALLIN K. H., POULSEN G., MELGAARD D., FRANDSEN T., JESS T., KRARUP A. L. Eosinophilic oesophagitis in Denmark: Population-based incidence and prevalence in a nationwide study from 2008 to 2018, United Eur. Gastroenterol. J., vol. 10, no. 7, pp. 640650, Sep. 2022.
  4. MUIR A., FALK G. W. Eosinophilic Esophagitis: A Review, JAMA, vol. 326, no. 13, pp. 13101318, Oct. 2021.
  5. FEO-ORTEGA S., LUCENDO A. J. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician, Ther. Adv. Gastroenterol., vol. 15, p. 17562848211068665, 2022.
  6. BEVERIDGE C., FALK G. W. Novel Therapeutic Approaches to Eosinophilic Esophagitis, Gastroenterol. Hepatol., vol. 16, no. 6, pp. 294301, Jun. 2020.
  7. DOBBINS J. W., SHEAHAN D. G., BEHAR J. Eosinophilic gastroenteritis with esophageal involvement, Gastroenterology, vol. 72, no. 6, pp. 13121316, Jun. 1977.
  8. FURUTA G. T., KATZKA D. A. Eosinophilic Esophagitis, N. Engl. J. Med., vol. 373, no. 17, pp. 16401648, Oct. 2015.
  9. DELLON E. S., GONSALVES N., HIRANO I., FURUTA G. T., LIACOURAS C. A., KATZKA D. A. ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE), Am. J. Gastroenterol., vol. 108, no. 5, pp. 679692, May 2013.
  10. DELLON E. S., HIRANO I. Epidemiology and Natural History of Eosinophilic Esophagitis, Gastroenterology, vol. 154, no. 2, pp. 319-332.e3, Jan. 2018.
  11. PITLICK M. M., LI J. T., PONGDEE T. Current and emerging biologic therapies targeting eosinophilic disorders, World Allergy Organ. J., vol. 15, no. 8, p. 100676, Aug. 2022.
  12. HIRANO I., FURUTA G. T. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis, Gastroenterology, vol. 158, no. 4, pp. 840851, Mar. 2020.
  13. LUCENDO A. J. et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults, United Eur. Gastroenterol. J., vol. 5, no. 3, pp. 335358, Apr. 2017.
  14. MAYERHOFER C., KAVALLAR A. M., ALDRIAN D., LINDNER A. K., MÜLLER T., VOGEL G. F. Efficacy of Elimination Diets in Eosinophilic Esophagitis: A Systematic Review and Meta-analysis, Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc., vol. 21, no. 9, pp. 2197-2210.e3, Aug. 2023.
  15. KUANG F. L. et al. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease, J. Allergy Clin. Immunol. Pract., vol. 10, no. 6, pp. 1598-1605.e2, Jun. 2022.
DOI: https://doi.org/10.2478/rjim-2024-0021 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 356 - 361
Submitted on: Jan 1, 2024
Published on: Jun 7, 2024
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Grigorios Petrousis, Pavlos Retsas, Simone Ignatova, Dimitrios Karapiperis, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.